The traditional classification of myeloid cells in the periphery and MDSC at the tumor site have recently been revised using several modern technologies, aiming at categorizing single cells based on their gene signature (single-cell RNAseq) and expression of cell surface receptors and some intracellular proteins (mass cytometry, CyTOF). Here, CD177 is linked to neoplasm.